| 產品名稱 | Borrelia burgdorferi Johnson et al. emend. Baranton et al. |
|---|---|
| 商品貨號 | B161418 |
| Strain Designations | B31 |
| Application | Emerging infectious disease research Vector borne research |
| Isolation | Tick, Ixodes dammini, New York |
| Biosafety Level | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format | frozen |
| Storage Conditions | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol® | no |
| Genome Sequenced Strain | Borrelia burgdorferi B31, complete genome. |
| Type Strain | yes |
| Comments | Genome sequencing strain Absence of lipopolysaccharide Lyme disease In vitro cultivation Survival in experimentally infected human blood Genome sequenced strain Infectivity of the strain in mice has not been confirmed at ATCC |
| Medium | ATCC® Medium 1914: Revised BSK medium |
| Growth Conditions | Temperature: 37°C Atmosphere: Microaerophilic |
| Name of Depositor | AG Barbour |
| Chain of Custody | ATCC <-- AG Barbour <-- W Burgdorfer |
| References | Johnson RC, et al. Borrelia burgdorferi sp. nov.: Etiologic agent of Lyme disease. Int. J. Syst. Bacteriol. 34: 496-497, 1984. Baranton G, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42: 378-383, 1992. PubMed: 1380285 Barbour AG. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57: 521-525, 1984. PubMed: 6393604 Takayama K, et al. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55: 2311-2313, 1987. PubMed: 3623705 Johnson SE, et al. Borrelia burgdorferi: survival in experimentally infected human blood processed for transfusion. J. Infect. Dis. 162: 557-559, 1990. PubMed: 2373880 Burgdorfer W, et al. Lyme disease-a tick-borne spirochetosis. Science 216: 1317-1319, 1982. PubMed: 7043737 van Dam AP, et al. Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect. Immun. 65: 1228-1236, 1997. PubMed: 9119456 Shang ES, et al. Sequence analysis and characterization of a 40-kilodalton Borrelia hermsii glycerophosphodiester phosphodiesterase homolog. J. Bacteriol. 179: 2238-2246, 1997. PubMed: 9079909 Valsangiacomo C, et al. A phylogenetic analysis of Borrelia burgdorferi sensu lato based on sequence information from the hbb gene, coding for a histone-like protein. Int. J. Syst. Bacteriol. 47: 1-10, 1997. PubMed: 8995795 Barbour AG, et al. The nucleotide sequence of a linear plasmid of Borrelia burdorferi reveals similarities to those of circular plasmids of other prokaryotes. J. Bacteriol. 178: 6635-6639, 1996. PubMed: 8932323 Ferdows MS, et al. Conversion of a linear to a circular plasmid in the relapsing fever agent Borrelia hermsii. J. Bacteriol. 178: 793-800, 1996. PubMed: 8550515 Skare JT, et al. Porin activity of the native and recombinant outer membrane protein Oms28 of Borrelia burgdorferi. J. Bacteriol. 178: 4909-4918, 1996. PubMed: 8759855 Fraser CM, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390: 580-586, 1997. PubMed: 9403685 Bunikis J, et al. Surface exposure and species specificity of an immunoreactive domain of a 66-kilodalton outer membrane protein (P66) of the Borrelia spp. that cause lyme disease. Infect. Immun. 64: 5111-5116, 1996. PubMed: 8945554 Xu Y, et al. Correlation of plasmids with infectivity of Borrelia burgdorferi sensu stricto type strain B31. Infect. Immun. 64: 3870-3876, 1996. PubMed: 8751941 Roessner K, et al. Biased t-cell antigen receptor repertoire in lyme arthritis. Infect. Immun. 66: 1092-1099, 1998. PubMed: 9488400 Casjens S, et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 32: 490-516, 2000. PubMed: 10672174 Western Blot Assay for Antibodies to Borrelia burgdorferi; Approved Guideline. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M34-A. Bontemps-Gallo S, et al. Genomic and phenotypic characterization of Borrelia afzelii BO23 and Borrelia garinii CIP 103362. PLoS One 13(6):e0199641, 2018. PubMed: 29944685 |
| Cross References | Nucleotide (GenBank) : M90084 Borrelia burgdorferi 22 kD antigen. Nucleotide (GenBank) : M34710 Borrelia burgdorferei flagellin (fla) gene, 5' end. Nucleotide (GenBank) : M59293 Borrelia burgdorferi small subunit ribosomal RNA sequence. Nucleotide (GenBank) : U76405 Borrelia burgdorferi vmp-like vlsE (vlsE1) gene, complete cds. Nucleotide (GenBank) : S75873 60 kda antigen [Borrelia coriaceae, Co53, ATCC 35210, Genomic, 1873 nt]. Nucleotide (GenBank) : U01894 Borrelia burgdorferi B31 outer surface protein C (ospC) gene, complete cds. Nucleotide (GenBank) : U76406 Borrelia burgdorferi putative vls recombination cassettes Vls2-Vls16b (vls) gene, complete sequence. Nucleotide (GenBank) : AE000783 Borrelia burgdorferi B31, complete genome. Nucleotide (GenBank) : AE001115 Borrelia burgdorferi B31 (section 1 of 70) of the complete genome. |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
